Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

High Vacuum Benchtop Solvent Evaporator

Published: Friday, July 11, 2014
Last Updated: Friday, July 11, 2014
Bookmark and Share
The EZ-2 Elite Centrifugal Evaporator from Genevac.

The EZ-2 Elite Centrifugal Evaporator from Genevac has been designed to provide unmatched final drying of stubborn samples and fast lyophilization of HPLC fractions.

Benefiting from a high performance scroll pump, that delivers deep vacuum, the EZ-2 Elite is able to routinely remove even very high boiling solvents such as DMSO and NMP.

In addition internal heating of vapour duct and system components ensures that such challenging solvents only collect in the SpeedTrap™ condensor, and not anywhere else.

The SpeedTrap condenser on the EZ-2 Elite comes the benefit of automatic defrost and drain technology. The EZ-2 controls the SpeedTrap and the Elite solvent collection vessel offering mid-method defrosting and draining. Using the EZ-2 Elite SpeedTrap - the Genevac LyoSpeed™ method of fast lyophilization of HPLC fractions is possible on an EZ-2 Evaporator.

The EZ-2 Elite is able to concentrate or completely dry samples. The system is compatible with a wide selection of sample holders enabling evaporation from most common sample container formats including round-bottom flasks up to 500ml, tubes up to 160mm long, custom reaction blocks as well as shallow and deep-well microplates.

To meet the need of the many life science companies switching their compound generation programmes from serial chemistry to parallel synthesis, the EZ-2 Elite is also able to take tubes, flasks and vials directly from the synthesis process, eliminating a manual handling step, increasing recoveries and removing the chance of cross contamination.

Running the EZ-2 Elite is highly intuitive. Just load samples, select maximum safe temperature for samples, select solvent type and hit start. Offering true unattended operation capability the EZ-2 Elite requires no user training, even a beginner can competently use the system within 5 minutes.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Genevac Consolidate Evaporator & Freeze Dryer Sales Channels in the UK
Company appoints BioPharma Process Systems as exclusive UK distributor.
Thursday, May 15, 2014
GenVec Announces Manufacturing Agreement for TNFerade™
The agreement will cover technology transfer, scale-up, and validation of the manufacturing process for TNFerade through cGMP consistency lots.
Friday, January 25, 2008
Genevac Launches new Information-rich Website
According to Genevac its new website is an information hub for evaporation, concentration and lyophilization.
Tuesday, November 27, 2007
Genevac Ltd. Acquired by Riverlake Partners
The acquisition of Genevac from Thermo Scientific will play a critical role in Riverlake's SP Industries for future growth and expansion.
Friday, April 13, 2007
New Approach to Compound Library Maintenance
The report describes a new high throughput process to produce compound libraries as dry films that have been validated for long-term storage.
Thursday, April 06, 2006
Genevac Moves on WEEE Compliance
As a result of upgrade and trade-in schemes over the last year, Genevac took back and has recycled 150 evaporators.
Tuesday, March 21, 2006
High-throughput Evaporation of Strongly Acidic Chemicals
The new version of the HT-12 Series II system has been introduced to provide laboratories with a highly efficient and safe means of routinely removing strongly acidic chemicals from their samples.
Thursday, July 14, 2005
Genevac DD- 4 & Metz Syn10 on Display at Labautomation 2002

Monday, January 14, 2002
Scientific News
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Keeping Tumor Growth at Bay
Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
Improving Delivery of Poorly Soluble Drugs Using Nanoparticles
A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Nanoparticles Deliver Tumor Suppressors to Damaged Livers
UT Southwestern Medical Center chemists have successfully used synthetic nanoparticles to deliver tumor-suppressing therapies to diseased livers with cancer, an important hurdle scientists have been struggling to conquer.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
A New Type of Anticancer Agent
Success in the development of a ?-tubulin specific inhibitor.
Nanoparticles Proven Effective Against Antibiotic-Resistant “Superbugs”
In the ever-escalating evolutionary battle with drug-resistant bacteria, humans may soon have a leg up thanks to adaptive, light-activated nanotherapy developed by researchers at the University of Colorado Boulder.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!